TRES CANTOS OPEN LAB FOUNDATION
TO FUND AND SUPPORT RESEARCH AT, OR IN COLLABORATION, WITH GSK'S R&D FACILITIES IN TRES CANTOS, SPAIN INTO MEDICINES FOR DISEASES OF THE DEVELOPING WORLD (INCLUDING, BUT NOT LIMITED TO MALARIA, TUBERCULOSIS, AND OTHER NEGLECTED DISEASES WHICH ARE IDENTIFIED BY THE CHARITY FROM TIME TO TIME).
Financial health, per its FY2024 accounts
The accounts state that the charity held unrestricted reserves of £2,080,329 at the end of the year, a decrease from £2,884,259 in the prior year. The charity reported a net expenditure deficit of £803,930 for the year, funded by incoming resources of £951,586. The trustees confirmed the charity is a going concern with sufficient cash resources to cover committed projects and expenses for the next 1.5 years.
What the accounts disclose
“The Directors set a target to have a level of free reserves to be able to fund future grants and meet the general running costs, which are usually an amount of circa £500k per year.” — page 8
“In the year Glaxo Group Limited provided £657,685 (2023: £454,901) of donated services to the Charity in the form of staff time spent on TCOLF activities.” — page 25
“During the year to 31 December 2024 TCOLF incurred fees payable to GSK amounting to £135,419 (2023: £148,031).” — page 25
“In the year Glaxo Group Limited provided £657,685 (2023: £454,901) of donated services to the Charity in the form of staff time spent on TCOLF activities.” — page 25
“During the year to 31 December 2024 TCOLF incurred fees payable to GSK amounting to £135,419 (2023: £148,031).” — page 25
Corporate structure
- Registered company of the charity Companies House 07301222
Company officers (Companies House)
- MIZRAHI, Valerie on trustee list
- SHELDON, Steven on trustee list
- DUNCAN, Kenneth on trustee list
- NATHAN, Carl Francis, Professor on trustee list
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Kenneth Duncan
- PROFESSOR ALAN HUTCHINSON FAIRLAMB CBE
- Professor Carl Francis Nathan
- Steven Sheldon
- Valerie Mizrahi
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £952k | £1.8m |
| 31/12/2023 | £737k | £1.5m |
| 31/12/2022 | £343k | £2.4m |
| 31/12/2021 | £5.3m | £1.3m |
| 31/12/2020 | £324k | £2.6m |
Common questions
Is TRES CANTOS OPEN LAB FOUNDATION financially healthy?
Per its FY2024 accounts: The accounts state that the charity held unrestricted reserves of £2,080,329 at the end of the year, a decrease from £2,884,259 in the prior year. The charity reported a net expenditure deficit of £803,930 for the year, funded by incoming resources of £951,586. The trustees confirmed the charity is a going concern with sufficient cash resources to cover committed projects and expenses for the next 1.5 years. Its FY2024 accounts were audited by RSM UK Audit LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE CHILDREN'S INVESTMENT FUND FOUNDATION (UK) | 1 | £17.9m |
| THE VIRGIN FOUNDATION | 1 | £2.8m |
| MOONDANCE FOUNDATION | 1 | £2.0m |
| EFFECTIVE VENTURES FOUNDATION | 1 | £1.4m |
| DELTA PHILANTHROPIES | 1 | £1.3m |
| THE SEQUOIA TRUST | 1 | £775k |
| JAMES PERCY FOUNDATION | 1 | £566k |
| THE CYNARA FOUNDATION | 1 | £565k |
Charities like this
- MALARIA CONSORTIUM
- THE YUSUF AND FARIDA HAMIED FOUNDATION
- WANDSWORTH OASIS TRADING COMPANY LIMITED
- THE INTERNATIONAL CML FOUNDATION
- STOCKPORT NHS FOUNDATION TRUST GENERAL FUND
- Open City
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| TRES CANTOS OPEN LAB FOUNDATION | £952k | — | 0 | unclear | — | no doubt |
| MALARIA CONSORTIUM | £72.2m | — | — | above | — | no doubt |
| THE YUSUF AND FARIDA HAMIED FOUNDATION | £7.3m | — | 0 | unclear | — | no doubt |
| WANDSWORTH OASIS TRADING COMPANY LIMITED | £1.1m | — | 0 | unclear | — | no doubt |
| THE INTERNATIONAL CML FOUNDATION | £267k | £80,001 - £90,000 | 1 | unclear | 13.0% | no doubt |
| STOCKPORT NHS FOUNDATION TRUST GENERAL FUND | £930k | — | 0 | above | — | no doubt |